Aging Baby Boomers enlarge potential customer base for the Cardiac Device markets

An increasing demand for minimally invasive surgeries amongst the rapidly aging population is expected to spark further growth in the cardiovascular devices market. Moreover, the cost efficiencies offered by lesser invasive methods expect to garner much favor amongst the healthcare payers as well.

Frost & Sullivan finds that North American Cardiovascular Devices Market earned revenues of $17.88 billion in 2005 and estimates this to reach $40.46 billion in 2011.

If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants an overview of the latest analysis of the North American Cardiovascular Devices Market: Investment Analysis and Growth Opportunities, then send an e-mail to Melina Trevino - Corporate Communications at melina.trevino@frost.com with the following information: your full name, company name, title, telephone number, e-mail address, city, state, and country. We will send you the information via email upon receipt of the above information.

By 2030, estimates of people aged 65 years and above will constitute 20 percent of the U.S. population, up 12.5 percent from 2005. This sector poses a significant opportunity for the cardiovascular devices industry, as the occurrence of heart related diseases is the highest in this age group.

“Demographics, historically has and will continue to be one of the major factors that drive growth in the cardiovascular devices market,” notes Frost & Sullivan Financial Analyst Sheetal Rajani.

Minimally invasive surgeries are gaining ground with both the patient population as well as cardiologists. These surgeries are associated with lesser trauma, shorter recovery time and lesser postoperative pain for the patient. Cardiologists stand to gain from the same too as the number of surgeries performed at a given time can increase.

“Companies need to continually invest in research and development in order to develop devices that could convert a surgery from an in-patient to an outpatient setting,” explains Rajani. “This will guarantee strong revenue growth and provide enhanced value to the patients as well as cardiologists.”